Advertisement
Adult urology| Volume 66, ISSUE 6, P1234-1238, December 2005

Download started.

Ok

Effect of prostatic massage on serum complexed prostate-specific antigen levels

      Abstract

      Objectives

      To evaluate the effects of prostatic massage on the serum complexed PSA (cPSA) concentration in various prostatic diseases.

      Methods

      A total of 51 men who presented to our outpatient clinic for the first time with symptoms of lower urinary outflow obstruction were included in this study. Blood samples were obtained from each patient before and 30 minutes after prostatic massage. Total PSA (tPSA), free PSA (fPSA), and cPSA levels were measured using a chemiluminescent enzyme immunoassay.

      Results

      After prostatic massage, the tPSA and fPSA levels and fPSA/tPSA ratio increased significantly (P <0.0001), and the increase in cPSA was minimal but statistically significant (P = 0.047). In patients with prostate cancer, no significant increase occurred in the mean forms of PSA (tPSA, cPSA, and fPSA/tPSA ratio), except for fPSA, after prostatic massage. We observed a greater increase in all PSA forms in the chronic prostatitis group.

      Conclusions

      In this study, prostatic massage increased serum cPSA concentration, but to a lesser extent than tPSA and fPSA.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wang M.C.
        • Valenzuela L.A.
        • Murphy G.P.
        • et al.
        Purification of a human prostate-specific antigen.
        Invest Urol. 1979; 17: 159-163
        • Bunting P.S.
        A guide to the interpretation of serum prostate specific antigen levels.
        Clin Chem. 1995; 28: 221-241
        • Klein L.T.
        • Lowe F.C.
        The effects of prostatic manipulation on prostatic-specific antigen levels.
        Urol Clin North Am. 1997; 24: 293-297
        • Brawer M.K.
        • Schifman R.B.
        • Ahmann F.R.
        • et al.
        The effect of digital rectal examination on serum levels of prostate-specific antigen.
        Arch Pathol Lab Med. 1988; 112: 1110-1112
        • Chybowski F.M.
        • Bergstralh E.J.
        • Oesterling J.E.
        The effect of digital rectal examination on the serum levels of prostate-specific antigen concentration.
        J Urol. 1992; 148: 83-86
        • Crawford E.D.
        • Schutz M.J.
        • Clejan S.
        • et al.
        The effect of digital rectal examination on PSA levels.
        JAMA. 1992; 267: 2227-2228
        • Collins G.N.
        • Martin P.J.
        • Wynn-Davies A.
        • et al.
        The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice.
        J Urol. 1997; 157: 1744-1747
        • Çevik I.
        • Turkeri L.N.
        • Ozveri H.
        • et al.
        Short-term effect of digital rectal examination on serum prostate-specific antigen levels.
        Eur Urol. 1996; 29: 403-406
        • Lynn N.N.K.
        • Collins G.N.
        • O’Reilly P.H.
        Prostatic manipulation has a minimal effect on complexed prostate-specific antigen levels.
        BJU Int. 2000; 86: 65-67
        • Lechevallier E.
        • Eghazarian C.
        • Ortega J.C.
        • et al.
        Effect of digital rectal examination on serum complexed and free prostatic-specific antigen and percentage of free prostate-specific antigen.
        Urology. 1999; 54: 857-861
        • Deliveliotis C.H.
        • Alivization G.
        • Stavropoulos N.J.
        • et al.
        Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate-specific antigen.
        Urol Int. 1994; 53: 186-190
        • Oberpenning F.
        • Schid H.P.
        • Surdel W.F.
        • et al.
        The impact of intraoperative manipulation of the prostate on total and free prostate-specific antigen.
        Int J Biol Markers. 2002; 17: 154-160
        • Yuan J.J.
        • Coplen D.E.
        • Petros J.A.
        • et al.
        Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels.
        J Urol. 1992; 147: 810-814
        • Sahin A.
        • Ozen H.
        • Balbay D.
        • et al.
        Effects of prostatic massage on serum levels of prostatic acid phosphatase and specific antigen.
        Bull Cancer. 1992; 79: 1097-1100
        • Stamey T.A.
        • Yang N.
        • Hay A.R.
        • et al.
        Prostate specific antigen as a serum marker for adenocarcinoma of the prostate.
        N Engl J Med. 1987; 317: 906-916
        • Bossens M.M.F.
        • Van Straalen J.P.
        • De Reijke T.M.
        • et al.
        Kinetics of prostate-specific antigen after manipulation of the prostate.
        Eur J Cancer. 1995; 31A: 682-685
        • Catalona W.J.
        • Smith D.S.
        • Ornstein D.K.
        Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination.
        JAMA. 1997; 277: 1452-1455
        • Okihara K.
        • Fritsche H.A.
        • Ayala A.
        • et al.
        Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.
        J Urol. 2001; 165: 1930-1936
        • Catalona W.J.
        • Partin A.W.
        • Slawin K.M.
        • et al.
        Use of percentage of free prostate specific antigen to enhance differentiation of prostate cancer from benign prostatic disease.
        JAMA. 1998; 279: 1542-1547
        • El-Shirbiny A.M.
        • Nilson T.
        • Pawar H.N.
        Serum prostate-specific antigen.
        Urology. 1990; 35: 88-92
        • Walz P.H.
        • Shoppmann T.
        • Buscher C.
        • et al.
        Influence of prostatic disease and prostatic manipulations on the concentration of prostate specific antigen.
        Eur Urol. 1992; 22: 20-26
        • Rodriguez-Rubio F.I.
        • Robles J.E.
        • Gonzales A.
        • et al.
        Effect of digital rectal examination and flexible cystoscopy on free and total prostatic-specific antigen and percentage of free prostate-specific antigen.
        Eur Urol. 1998; 33: 255-260
        • Kılıç S.
        • Yalçınkaya S.
        • Güntekin E.
        • et al.
        Determination of the site of metabolism of total, free and complexed prostate-specific antigen.
        Urology. 1998; 52: 470-473
        • Leinonen J.
        • Zhang W.M.
        • Stenman U.H.
        Complex formation between PSA isoenzymes and protease inhibitors.
        J Urol. 1996; 155: 1099-1103
        • Hasui Y.
        • Marutsuka K.
        • Asada Y.
        • et al.
        Relationship between serum prostate-specific antigen and histological prostatitis in patients with benign prostatic hyperplasia.
        Prostate. 1994; 25: 91-96
        • Nadler R.B.
        • Humphrey P.A.
        • Smith D.S.
        • et al.
        Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate-specific antigen levels.
        J Urol. 1995; 154: 407-413
        • Alexandrou K.
        • Collins G.N.
        • Wynn-Davies A.
        • et al.
        A critical evaluation of prostate specific antigen parameter responses to manipulation according to prostatic histology.
        Prostate J. 1999; 1: 93-98
        • Bjork T.
        • Hulkko S.
        • Bjartell A.
        • et al.
        Alpha1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia.
        Urology. 1994; 43: 427-434